KMPHARMACEUTICAL Statistics

Total Valuation

KOSDAQ:225430 has a market cap or net worth of KRW 17.32 billion. The enterprise value is 31.06 billion.

Market Cap	17.32B
Enterprise Value	31.06B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:225430 has 27.89 million shares outstanding. The number of shares has decreased by -6.52% in one year.

Current Share Class	27.89M
Shares Outstanding	27.89M
Shares Change (YoY)	-6.52%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	38.79%
Owned by Institutions (%)	n/a
Float	17.07M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.23
PB Ratio	0.54
P/TBV Ratio	0.55
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-6.36
EV / Sales	2.20
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-16.08

Financial Position

The company has a current ratio of 0.54, with a Debt / Equity ratio of 0.46.

Current Ratio	0.54
Quick Ratio	0.28
Debt / Equity	0.46
Debt / EBITDA	n/a
Debt / FCF	-7.65
Interest Coverage	-7.01

Financial Efficiency

Return on equity (ROE) is -14.63% and return on invested capital (ROIC) is -5.47%.

Return on Equity (ROE)	-14.63%
Return on Assets (ROA)	-5.20%
Return on Invested Capital (ROIC)	-5.47%
Return on Capital Employed (ROCE)	-10.63%
Revenue Per Employee	242.90M
Profits Per Employee	-84.16M
Employee Count	58
Asset Turnover	0.28
Inventory Turnover	4.77

Taxes

In the past 12 months, KOSDAQ:225430 has paid 371.56 million in taxes.

Income Tax	371.56M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -28.31% in the last 52 weeks. The beta is 0.43, so KOSDAQ:225430's price volatility has been lower than the market average.

Beta (5Y)	0.43
52-Week Price Change	-28.31%
50-Day Moving Average	624.24
200-Day Moving Average	623.07
Relative Strength Index (RSI)	47.86
Average Volume (20 Days)	64,483

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:225430 had revenue of KRW 14.09 billion and -4.88 billion in losses. Loss per share was -173.92.

Revenue	14.09B
Gross Profit	3.37B
Operating Income	-4.13B
Pretax Income	-4.51B
Net Income	-4.88B
EBITDA	-2.84B
EBIT	-4.13B
Loss Per Share	-173.92

Full Income Statement

Balance Sheet

The company has 1.02 billion in cash and 14.77 billion in debt, giving a net cash position of -13.74 billion or -492.81 per share.

Cash & Cash Equivalents	1.02B
Total Debt	14.77B
Net Cash	-13.74B
Net Cash Per Share	-492.81
Equity (Book Value)	31.79B
Book Value Per Share	1,139.99
Working Capital	-4.97B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.54 billion and capital expenditures -387.47 million, giving a free cash flow of -1.93 billion.

Operating Cash Flow	-1.54B
Capital Expenditures	-387.47M
Free Cash Flow	-1.93B
FCF Per Share	-69.27

Full Cash Flow Statement

Margins

Gross margin is 23.95%, with operating and profit margins of -29.29% and -34.65%.

Gross Margin	23.95%
Operating Margin	-29.29%
Pretax Margin	-32.01%
Profit Margin	-34.65%
EBITDA Margin	-20.12%
EBIT Margin	-29.29%
FCF Margin	n/a

Dividends & Yields

KOSDAQ:225430 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	6.52%
Shareholder Yield	n/a
Earnings Yield	-28.19%
FCF Yield	-11.15%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KOSDAQ:225430 has an Altman Z-Score of 1.05 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.05
Piotroski F-Score	2